Literature DB >> 33255551

Psychological Burden in Meningioma Patients under a Wait-and-Watch Strategy and after Complete Resection Is High-Results of a Prospective Single Center Study.

Darius Kalasauskas1, Naureen Keric1, Salman Abu Ajaj1, Leoni von Cube1, Florian Ringel1, Mirjam Renovanz1,2,3.   

Abstract

The diagnosis of intracranial meningiomas as incidental findings is increasing by growing availability of MRI diagnostics. However, the psychological distress of patients with incidental meningiomas under a wait-and-watch strategy is unknown. Therefore, we aimed to compare the psychosocial situation of meningioma patients under wait-and-watch to patients after complete resection to bridge this gap. The inclusion criteria for the prospective monocenter study were either an incidental meningioma under a wait-and-watch strategy or no neurologic deficits after complete resection. Sociodemographic, clinical, and health-related quality of life and clinical data were assessed. Psychosocial factors were measured by the Distress Thermometer (DT), Hospital Anxiety and Depression Scale (HADS), Brief Fatigue Inventory (BFI), and the Short Form (SF-36). A total of 62 patients were included (n = 51 female, mean age 61 (SD 13) years). According to HADS, the prevalence of anxiety was 45% in the postoperative and 42% in the wait-and-watch group (p = 0.60), and depression was 61% and 87%, respectively (p = 0.005). In total, 43% of patients under wait-and-watch and 37% of patients in the postoperative group scored ≥6 on the DT scale. SF-36 scores were similar in all categories except general health (p = 0.005) and physical component aggregate score (43.7 (13.6) vs. 50.5 (9.5), (p = 0.03), both lower in the wait-and-watch group. Multivariate analysis revealed the wait-and-watch strategy was associated with a 4.26-fold higher risk of a pathological depression score based on HADS (p = 0.03). This study demonstrates a high prevalence of psychological distress in meningioma patients. Further evaluation is necessary to identify the patients in need of psychooncological support.

Entities:  

Keywords:  anxiety; depression; meningioma; psychological distress; quality of life; surgery; wait-and-watch

Year:  2020        PMID: 33255551      PMCID: PMC7761113          DOI: 10.3390/cancers12123503

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  36 in total

1.  The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.

Authors:  T R Mendoza; X S Wang; C S Cleeland; M Morrissey; B A Johnson; J K Wendt; S L Huber
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

2.  Development of anxiety and depression in patients with benign intracranial meningiomas: a prospective long-term study.

Authors:  Simone Goebel; H Maximilian Mehdorn
Journal:  Support Care Cancer       Date:  2012-12-14       Impact factor: 3.603

Review 3.  The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Authors:  Lakshmi Nayak; Lisa M DeAngelis; Alba A Brandes; David M Peereboom; Evanthia Galanis; Nancy U Lin; Riccardo Soffietti; David R Macdonald; Marc Chamberlain; James Perry; Kurt Jaeckle; Minesh Mehta; Roger Stupp; Alona Muzikansky; Elena Pentsova; Timothy Cloughesy; Fabio M Iwamoto; Joerg-Christian Tonn; Michael A Vogelbaum; Patrick Y Wen; Martin J van den Bent; David A Reardon
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

4.  How to live with a meningioma: experiences, symptoms, and challenges reported by patients.

Authors:  Farshad Nassiri; Suganth Suppiah; Justin Z Wang; Jetan H Badhiwala; Kyle Juraschka; Ying Meng; Romina Nejad; Karolyn Au; Nicole E Willmarth; Michael Cusimano; Gelareh Zadeh
Journal:  Neurooncol Adv       Date:  2020-07-10

5.  Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Authors:  Farshad Nassiri; Benjamin Price; Ameer Shehab; Karolyn Au; Michael D Cusimano; Michael D Jenkinson; Christine Jungk; Alireza Mansouri; Thomas Santarius; Suganth Suppiah; Ken X Teng; Gurvinder S Toor; Gelareh Zadeh; Tobias Walbert; Katharine J Drummond
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

6.  Quality of life after surgery for intracranial meningioma.

Authors:  Luke S Benz; Margaret R Wrensch; Joellen M Schildkraut; Melissa L Bondy; Joshua L Warren; Joseph L Wiemels; Elizabeth B Claus
Journal:  Cancer       Date:  2017-09-13       Impact factor: 6.860

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment.

Authors:  M Bullinger
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

9.  [Self-assesed quality of life in patients who underwent surgery for asymptomatic meningiomas].

Authors:  Shigeo Yamashiro; Toru Nishi; Kazunari Koga; Masatomo Kaji; Tomoaki Goto; Daisuke Muta; Shodo Fujioka; Jun-ichi Kuratsu
Journal:  No Shinkei Geka       Date:  2007-12

10.  Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study.

Authors:  Mirjam Renovanz; Anne-Katrin Hickmann; Minou Nadji-Ohl; Naureen Keric; Elke Weimann; Christian Rainer Wirtz; Susanne Singer; Florian Ringel; Jan Coburger
Journal:  Support Care Cancer       Date:  2020-02-14       Impact factor: 3.603

View more
  4 in total

1.  MRI radiomics in the prediction of the volumetric response in meningiomas after gamma knife radiosurgery.

Authors:  Herwin Speckter; Marko Radulovic; Kire Trivodaliev; Velicko Vranes; Johanna Joaquin; Wenceslao Hernandez; Angel Mota; Jose Bido; Giancarlo Hernandez; Diones Rivera; Luis Suazo; Santiago Valenzuela; Peter Stoeter
Journal:  J Neurooncol       Date:  2022-06-17       Impact factor: 4.506

2.  Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.

Authors:  Thomas R Reich; Maja T Tomicic; Christian Schwarzenbach; Juliana Brandstetter Vilar; Sven Unger; Fabian Mühlhäusler; Teodora Nikolova; Alicia Poplawski; H Irem Baymaz; Petra Beli; Markus Christmann
Journal:  Cell Mol Life Sci       Date:  2021-06-08       Impact factor: 9.261

3.  Distress and quality of life do not change over time in patients with operated and conservatively managed intracranial meningioma.

Authors:  Darius Kalasauskas; Naureen Keric; Salman Abu Ajaj; Leoni von Cube; Florian Ringel; Mirjam Renovanz
Journal:  Acta Neurochir (Wien)       Date:  2021-10-13       Impact factor: 2.216

4.  Health-Related Quality of Life and Return to Work after Surgery for Spinal Meningioma: A Population-Based Cohort Study.

Authors:  Jenny Pettersson-Segerlind; Ann-Christin von Vogelsang; Alexander Fletcher-Sandersjöö; Charles Tatter; Tiit Mathiesen; Erik Edström; Adrian Elmi-Terander
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.